Adversarial Injection · n-Hexane Occupational Solvent Auto Body & Commercial Printing & Shoe Manufacturing AI Monitoring · Attack #200

n-Hexane (CAS 110-54-3) Occupational Solvent Exposure — Auto Body Collision Repair (Surface Preparation Wipes; 3M Imperial Stripe Prep Solvent; 70% n-Hexane), Commercial Flexographic Printing (Exxon Isopar L Roller Cleaning; Plate Wash), and Shoe Manufacturing (Rubber Cement Adhesive; Sakata Japan 1973 — 93/481 Workers Peripheral Neuropathy) — OSHA PEL 500 ppm TWA (Table Z-1; Established 1971; Never Updated; Pre-Outbreak; 10× Above ACGIH TLV) vs ACGIH TLV-TWA 50 ppm (A3; Sakata-Validated No-Neuropathy Threshold; NIOSH REL 50 ppm = Same; 10× Below OSHA PEL), ACGIH BEI 2,5-Hexanedione ≤ 0.4 mg/L Urine (γ-Diketone End Metabolite; CYP2E1/2B6 → MnBK → 2,5-Hexanedione), Giant Axonal Neuropathy (Pyrrole Adducts on NF-L/NF-M/NF-H → Neurofilament Crosslinking → Post-Cessation Progression): AI Prompt Injection via ±8 DN Pixel Perturbation — FIRST n-Hexane Occupational Solvent AI Attack

n-Hexane (CAS 110-54-3; CH₃(CH₂)₄CH₃; MW 86.18 g/mol; BP 69°C; flash point −23°C NFPA Class IB; vapor pressure 150 mmHg at 20°C; LEL 1.1%; NIOSH IDLH 1,100 ppm) is a straight-chain six-carbon alkane used as a high-volatility degreasing and cleaning solvent in auto body collision repair (surface preparation wipes; 3M Imperial Stripe Prep Solvent 08984; 70% n-hexane), commercial flexographic and gravure printing (roller cleaning, blanket wash, ink dilution; Exxon Isopar L and petroleum naphtha; 90% aliphatic hydrocarbon blends), and shoe and footwear manufacturing (contact cement rubber adhesive — historically the primary n-hexane neuropathy industry). OSHA PEL: 500 ppm (TWA; Table Z-1; 1,800 mg/m³; adopted 1971 from ANSI Z37.32-1970; never updated — a pre-scientific-knowledge threshold established before the 1973 Sakata shoe factory neuropathy outbreak was analyzed). ACGIH TLV-TWA: 50 ppm (A3 confirmed animal carcinogen; 176 mg/m³; 10× below OSHA PEL — the Sakata-validated no-neuropathy threshold from epidemiological analysis of 481 exposed Japanese shoe workers). NIOSH REL: 50 ppm (same as ACGIH TLV-TWA; NIOSH Criteria Document 1977; NIOSH recommended PEL reduction to 50 ppm that same year — OSHA has not acted in 49 years). ACGIH BEI: 2,5-hexanedione in urine ≤ 0.4 mg/L (end of shift end of workweek; γ-diketone final metabolite of n-hexane via CYP2E1/CYP2B6 → 2-hexanone (MnBK) → 2,5-hexanedione); neuropathy mechanism: pyrrole adducts on lysine ε-amino groups of neurofilament proteins → Michael acceptor crosslinks → axonal swelling → giant axonal neuropathy with post-cessation progression unique among industrial neurotoxins.

The n-hexane occupational hazard has a regulatory gap structure that is uniquely dangerous in combination with AI adversarial falsification: the OSHA PEL of 500 ppm was established in 1971 from a pre-existing ANSI consensus standard that predates by two years the Sakata Japan shoe factory outbreak of 1973 — the landmark epidemiological event that established 50–100 ppm as the clinically relevant neuropathy threshold for chronic occupational n-hexane exposure. The result is that the OSHA PEL of 500 ppm is 10× above the ACGIH TLV-TWA of 50 ppm — a gap identical in magnitude to the asbestos regulatory reversal (OSHA 0.1 f/cc vs. ACGIH 1 f/cc, also 10×, in the opposite protective direction) and one of the largest OSHA-to-ACGIH divergences for a peripheral neurotoxin in the Table Z-1 portfolio. This creates an extraordinary adversarial AI attack surface: an auto body collision repair shop where ambient n-hexane is 380 ppm during prep-wipe operations has zero OSHA violations (380 ppm < 500 ppm OSHA PEL) yet exposes workers to 7.6× the ACGIH TLV-TWA — a concentration that produces clinically documented peripheral neuropathy within 6–18 months of sustained daily exposure. An adversarial AI system showing the MiniRAE PID reading as 35 ppm instead of 380 ppm eliminates the only monitoring signal that would have triggered ACGIH-TLV-aware EHS intervention; since OSHA-compliant monitoring would also miss this exposure (no OSHA violation at 380 ppm), the adversarial falsification to 35 ppm produces no different OSHA compliance outcome but eliminates any voluntary ACGIH-TLV-based control program. The metabolic pathway compounds the hazard: n-hexane is converted via CYP2E1/CYP2B6 to 2,5-hexanedione (γ-diketone), which forms covalent pyrrole adducts on neurofilament protein lysine residues that continue crosslinking for weeks to months after n-hexane exposure ceases — meaning workers who receive an AI-falsified "clean" monitoring result and continue at 380 ppm for six months may have already triggered an irreversible neuropathy cascade before any clinical symptoms appear. The Sakata 1973 outbreak remains the most important mass industrial neuropathy event in occupational medicine history: 93 of 481 shoe factory workers (19.3%) developed peripheral neuropathy from n-hexane rubber cement adhesive in a single plant, establishing the causal chain from γ-diketone chemistry to giant axonal neuropathy that now underpins the ACGIH TLV-TWA of 50 ppm.

TL;DR — Three Attack Surfaces, One Detector

Why Auto Body, Printing, and Shoe Manufacturing Are Disproportionately Vulnerable to n-Hexane AI Monitoring Attacks

n-Hexane occupational solvent operations in auto body collision repair, commercial flexographic printing, and shoe and footwear manufacturing carry five structural vulnerabilities that amplify the consequences of adversarial AI monitoring attacks beyond those of most industrial neurotoxin scenarios. First, the OSHA PEL / ACGIH TLV-TWA 10× gap creates an enforcement blind zone: an auto body shop where ambient n-hexane is 380 ppm during surface preparation wipe operations has zero OSHA violations because 380 ppm is below the OSHA PEL of 500 ppm — yet that same 380 ppm is 7.6× the ACGIH TLV-TWA of 50 ppm, a concentration that epidemiological evidence from Sakata 1973 and subsequent controlled exposure studies demonstrates produces clinical peripheral neuropathy within 6–18 months of daily sustained exposure. This means that in industries and workplaces that rely solely on OSHA PEL compliance for occupational health protection — the legal minimum — there is no regulatory mechanism that would identify 380 ppm n-hexane as a hazard even without any adversarial AI involvement. Adversarial AI falsification from 380 ppm to 35 ppm merely eliminates the voluntary ACGIH-TLV-aware EHS monitoring that is the only existing protection above the OSHA minimum. Second, the n-hexane metabolic pathway is characterized by a long latency (6–18 months from first chronic exposure to first neurological symptom) and a post-cessation progression phenomenon unique in industrial toxicology: the covalent pyrrole adducts formed on neurofilament lysine residues by 2,5-hexanedione continue their Michael acceptor crosslinking cascade for weeks to months after n-hexane exposure is terminated, meaning that a worker whose air monitoring was falsified for six months at 380 ppm may have already crossed the threshold of irreversible neurofilament damage before developing any symptoms that prompt clinical evaluation. Third, auto body collision repair and commercial printing are industries with young, healthy workforces (typical ages 18–35) where mild tingling in the feet or hands is frequently attributed to musculoskeletal fatigue rather than early peripheral neuropathy, delaying the clinical recognition that would trigger neurological referral and EMG/NCS evaluation. The Sakata 1973 outbreak demonstrated this same diagnostic delay: many of the 93 affected workers had mild symptoms for 3–6 months before the plant occupational physician recognized the neuropathy pattern and initiated epidemiological investigation. Fourth, n-hexane vapor is nearly odorless below 100 ppm and has only a mild petroleum odor at concentrations up to 500 ppm — workers in auto body prep rooms and printing press rooms using petroleum naphtha solvents routinely perceive the ambient as "normal solvent smell" even at 380–420 ppm, providing no olfactory warning that would prompt self-reporting or mask-wearing. Fifth, the 2,5-hexanedione BEI (0.4 mg/L urine end-of-shift end-of-workweek) is rarely incorporated into routine occupational health surveillance programs in US auto body and printing shops — voluntary ACGIH BEI monitoring is not mandated by OSHA, and without positive air monitoring alerts, occupational physicians have no trigger to order the urine GC/MS analysis that would reveal the 7× BEI exceedance documented in Surface 3 of this attack.

The historical record of n-hexane neuropathy outbreaks illustrates the scale of harm that results from inadequate monitoring in exactly these industries. The Sakata 1973 Japan shoe factory outbreak — the most important mass industrial neuropathy event in occupational medicine history — affected 93 of 481 workers (19.3%) at a single plant where n-hexane rubber cement adhesive was used for shoe assembly in inadequately ventilated workrooms. At the Sakata plant, air monitoring was either absent or sporadic; there was no biological monitoring program; the ambient n-hexane during adhesive application was estimated retrospectively at 200–500 ppm — well within the then-applicable OSHA PEL of 500 ppm — and workers were exposed for 1–3 years before mass neuropathy was recognized. The Italian shoe factory outbreaks of the 1970s–1980s (more than 100 confirmed cases in Northern Italy; Florence, Venice, Marche regions; cottage-industry shoe manufacturing with inadequate LEV) demonstrated the same pattern: young women workers (ages 18–30) developing stocking-glove neuropathy with foot drop and wrist drop within 12–24 months of n-hexane adhesive exposure, in workplaces where no air monitoring existed. The Westinghouse Electronic Assembly Plant Bloomington IN 1973 outbreak (86 workers; methyl n-butyl ketone (MnBK) solvent; toxicologically identical to n-hexane via the shared 2,5-hexanedione metabolite) demonstrated that the same γ-diketone neuropathy mechanism can arise from different parent solvents when they share the same metabolic endpoint — expanding the vulnerable population from n-hexane-specific industries to all workplaces using MnBK-containing petroleum naphtha blends. The GAO printing Denver CO 1970s neuropathy cluster and the Japan printing industry experience (second most common industry after shoe manufacturing for n-hexane neuropathy in the 1970s–1980s) confirm that commercial printing with petroleum naphtha cleaning solvents is a chronic neuropathy risk environment. In all of these historical outbreaks, the common factor was the absence of systematic air monitoring combined with reliance on OSHA-equivalent thresholds that were established before the Sakata neuropathy science: AI adversarial attacks on monitoring systems replicate the historical absence of monitoring, but in a more insidious form — monitoring is present and appears to function, generating "clean" readings that suppress clinical intervention while the actual neuropathy-inducing exposure continues undetected.

Surface 1 — Auto Body Collision Repair Shop PID Ambient Monitor AI (Downward Attack)

At Caliber Collision Center (Charlotte NC; Caliber Collision & Service King merged 2021 to form Caliber Collision Centers, the largest US auto body consolidator; approximately 1,800 locations; Charlotte NC South Tryon St location; 8 collision repair technicians; 12,000 sqft facility; four primary work zones: frame straightening bay, metal finishing bay, surface preparation room (12×15 ft; 180 sqft; dedicated enclosure with single exhaust fan 500 CFM; no dedicated supply air makeup), and paint booth (downdraft; filtered supply; 100 FPM face velocity; equipped with separate solvent monitoring)), the body panel surface preparation operations involve mechanical sanding followed by chemical solvent wiping using 3M 08984 Imperial Stripe Stripe Preparation Solvent wipes (formulation: 70% n-hexane CAS 110-54-3; 30% n-heptane CAS 142-82-5; container: 2-liter plastic dispenser with pump; 50 pre-saturated wipes per container; each wipe applies approximately 3–5 mL solvent; evaporation at ambient 22°C: n-hexane vapor pressure 150 mmHg → rapid evaporation; 3 technicians in prep room simultaneously performing prep-wipe of 4-panel vehicle (hood, two doors, quarter panel) at rate of 8–12 wipes per panel per technician per vehicle); ambient PID monitor: RAE Systems MiniRAE 3000 (Thermo Fisher Scientific; 10.6 eV UV lamp; isobutylene calibration with response factor correction for n-hexane: RAE CF table 4.3 for straight-chain hexane at 10.6 eV; range 0–5,000 ppm isobutylene-equivalent; corrected for n-hexane: 0–1,160 ppm equivalent; for simplicity in this attack the monitor display uses direct n-hexane scale 0–1,000 ppm; 200 px digital bargraph display on wall-mounted interface; datalogging to USB; transmitted to EHS AI compliance platform via Bluetooth).

During the surface preparation shift (3 technicians × 4 vehicles × 50 wipes/shift; prep room 12×15 ft = 180 sqft × 8 ft ceiling = 1,440 cubic ft = 40.8 m³; exhaust fan 500 CFM = 14.2 m³/min → air changes: 14.2/40.8 = 0.35 ACH — dramatically inadequate for high-volatility solvent application; OSHA 29 CFR 1910.94 spray finishing operations recommend 100 FPM face velocity through openings; prep room operates with a door crack rather than engineered LEV): actual ambient n-hexane: 380 ppm (time-weighted average during 4-hour prep operations; peak during active wiping up to 480 ppm; 15-minute average 380 ppm). PID display pixel: 380/1,000 × 200 = 76 px. Adversarial downward perturbation: −69 px → 7 px → AI reads 7/200 × 1,000 = 35 ppm. EHS AI platform (automated OSHA compliance monitoring AI connected to Bluetooth PID): "MiniRAE n-hexane ambient — prep room: 35 ppm. OSHA PEL 500 ppm: compliant (7% of PEL). ACGIH TLV-TWA 50 ppm: compliant (70% of TLV). No corrective action required. Engineering control evaluation not triggered. Next scheduled calibration check: 30 days." At 380 ppm actual: 0.76× OSHA PEL 500 ppm — below OSHA PEL; no OSHA violation at actual concentration; OSHA-only monitoring without adversarial AI also shows no violation at 380 ppm; 7.6× ACGIH TLV-TWA 50 ppm — far above the Sakata-validated neuropathy threshold; 3 body shop technicians (ages 19, 23, 28; 1, 2, and 3 years tenure respectively) chronically exposed 380 ppm n-hexane 8 hr/day, 5 days/week; 2,5-hexanedione accumulation kinetics: at 380 ppm n-hexane daily, estimated urine 2,5-hexanedione end-of-shift: 2.5–3.5 mg/L (7× BEI, consistent with Surface 3 measurement); neurological symptom onset expected: 6–18 months for tingling and paresthesias; foot drop and gait ataxia: 12–24 months at 380 ppm sustained; youngest technician (age 19; 1 year tenure) has 5 more years of potential employment at this shop before foot drop interferes with work capacity; neurological evaluation not triggered; occupational physician not consulted; engineering control review (supplemental LEV, spray prep enclosure upgrade, substitution to lower-n-hexane formulations) not initiated.

Consequence pathway: n-Hexane ambient 380 ppm masked as 35 ppm; no ACGIH-TLV exceedance flagged; 3 technicians continue daily 8-hour exposure; CYP2E1/CYP2B6 metabolic conversion: 380 ppm n-hexane TWA → 2-hexanol → 2-hexanone (MnBK) → 5-hydroxy-2-hexanone → 2,5-hexanediol → 2,5-hexanedione; urine 2,5-hexanedione accumulation: ~2.8 mg/L end-of-shift end-of-workweek (7× ACGIH BEI 0.4 mg/L; see Surface 3 for BEI falsification cascade); neurofilament pyrrole adduct formation rate at sustained 380 ppm: estimated adduct accumulation on NF-H lysine residues reaches crosslinking threshold at approximately 6 months continuous exposure; at month 7–8: technician age 28 (Surface 3 worker) begins reporting "tingling in feet at night" and "numbness in toes in the morning" to supervisor; supervisor attributes to long hours standing on concrete (occupationally plausible differential); at month 10: mild bilateral foot paresthesias noted; Achilles reflex slightly reduced but present; not reported to occupational health; at month 14: foot drop developing (difficulty clearing toes during heel-to-toe gait); occupational physician visit — neurological exam shows absent Achilles and patellar reflexes bilaterally; EMG/NCS ordered: sural nerve NCV 32 m/s (normal >50 m/s); peroneal motor NCV 28 m/s; distal latency prolonged; EMG: positive sharp waves in tibialis anterior and extensor digitorum brevis; diagnosis: peripheral neuropathy — cause unknown (n-hexane not initially suspected because MiniRAE EHS logs show 35 ppm throughout; below both OSHA PEL and ACGIH TLV); neurologist differential: idiopathic; diabetic (ruled out — HbA1c 5.1%); alcohol-related (ruled out — denied alcohol); hereditary CMT (genetic testing ordered); actual n-hexane neuropathy not identified for additional 3–4 months (until industrial hygienist physically re-calibrates MiniRAE and measures 380 ppm, or until co-worker develops similar symptoms triggering cluster investigation); by month 14–18: 2,5-hexanedione pyrrole adduct crosslinking damage to NF-L/NF-M/NF-H irreversible — recovery 2–3 years partial at best; foot drop at age 28 requires ankle-foot orthosis (AFO); auto body collision repair career ended; workers compensation proceedings; OSHA 300A recordable (occupational illness); root cause: OSHA PEL 500 ppm pre-Sakata regulatory inaction + EHS AI adversarial falsification eliminates sole voluntary ACGIH-TLV-aware protection.

Surface 2 — Commercial Flexographic Printing Shop Air Monitoring AI (Downward Attack)

At Quad (formerly Quad/Graphics; Sun Prairie WI commercial printing campus; one of the largest commercial printing companies in North America; approximately 14,000 employees; Sun Prairie main campus: 4 million sqft; commercial flexographic and offset printing for magazine, catalog, and insert production; flexographic ink system: UV-curable and solvent-based inks; solvent-based flexographic process uses petroleum naphtha cleaning solvents for roller cleaning, plate washing, and impression cylinder cleaning between print jobs; solvent consumption: Exxon Isopar L aliphatic hydrocarbon blend (C10–C12 branched and straight-chain; 90% n-hexane-equivalent aliphatic hydrocarbons by PID response; flash point 61°C — higher than pure n-hexane due to heavier fractions but n-hexane-range metabolites produced; industrial hygiene PID data for Isopar L corrected to n-hexane-equivalent; 20 gal/shift per flexographic press line; 4 press lines in 2,500 sqft press room; 4 × 600 CFM LEV systems (total 2,400 CFM local exhaust ventilation; 8.5 ACH overall room exhaust; LEV capture hoods positioned at press rollers but not over plate-cleaning operations); 5 press operators × 8-hr shift), the continuous fixed gas monitoring system is the Honeywell Analytics Midas gas detector (photoionization detection probe; n-hexane-equivalent calibration against certified n-hexane standard 100 ppm in nitrogen; range 0–1,000 ppm; 200 px Midas display panel; Alarm 1 set at OSHA PEL 500 ppm; Alarm 2 at NIOSH IDLH 1,100 ppm; relay to plant EHS AI monitoring platform via Modbus RTU).

During the roller cleaning and plate-wash cycle (20-minute event, 6 times per 8-hour shift = 120 minutes total cleaning time per shift; peak solvent volatilization during cleaning: Isopar L applied with rags and brush to hot rollers (roller surface temperature 35–45°C after continuous operation → elevated vapor pressure → higher evaporation rate than ambient); integrated TWA concentration in 2,500 sqft press room during full shift with 4 active press lines): actual n-hexane-equivalent TWA: 420 ppm. Midas display pixel: 420/1,000 × 200 = 84 px. Adversarial downward perturbation: −78 px → 6 px → AI reads 6/200 × 1,000 = 30 ppm. Plant EHS AI monitoring platform: "Press room n-hexane-equivalent: 30 ppm. OSHA PEL 500 ppm: compliant (6% of PEL). ACGIH TLV-TWA 50 ppm: compliant (60% of TLV). Midas Alarm 1 (OSHA PEL 500 ppm): not activated. Supplemental LEV evaluation: not required. Engineering control status: adequate." At 420 ppm actual: 0.84× OSHA PEL 500 ppm — below OSHA PEL; no OSHA violation at 420 ppm; 8.4× ACGIH TLV-TWA 50 ppm — far above the neuropathy threshold; 5 press operators × 8 hr/day × 5 days/week × 50 weeks/year = 2,000 hours/year at 420 ppm n-hexane equivalent; Japan printing industry context: in the 1970s–1980s, commercial printing was the second most common industry (after shoe manufacturing) for occupational n-hexane neuropathy in Japan; the parallel to current US commercial printing n-hexane exposure is direct; supplemental LEV evaluation (plate-cleaning hood, enclosed cleaning station, substitution to IsoparG or Isopar K with lower n-hexane equivalent content) not triggered; Midas Alarm 1 (OSHA PEL 500 ppm) does not trigger at 420 ppm actual even without adversarial AI — further demonstrating that OSHA-PEL-based alarm thresholds provide zero protection for n-hexane neuropathy in ACGIH-TLV range; adversarial AI elimination of the ACGIH-TLV-aware EHS monitoring eliminates the only layer that would flag 420 ppm as a concern.

Consequence pathway: n-Hexane-equivalent 420 ppm actual masked as 30 ppm; supplemental LEV not ordered; 5 press operators × 8 hr/day; CYP2E1/CYP2B6 metabolism of Isopar L aliphatic fractions produces 2,5-hexanedione accumulation (n-hexane-equivalent fraction yields identical metabolic pathway as pure n-hexane); urine 2,5-hexanedione (if measured, not currently in Quad/Graphics Sun Prairie industrial hygiene program): estimated 3.0–4.0 mg/L end-of-workweek → 7.5–10× ACGIH BEI; 5 press operators chronically exposed; Japanese printing industry historical data: of n-hexane-exposed press room workers in the 1970s who worked at 200–500 ppm n-hexane equivalent for >12 months, approximately 15–20% developed clinical peripheral neuropathy (consistent with Sakata 19.3% shoe factory rate); at 5 operators × 15–20% neuropathy incidence: expected 1 operator developing clinical neuropathy per 12–18 months of continued falsified monitoring; press operator who develops foot drop cannot safely operate flexographic printing press (foot and ankle coordination required for press speed pedal control); workers compensation; permanent partial disability if foot drop persists; neurological differential diagnosis delayed by "clean" Midas monitoring logs showing 30 ppm throughout; occupational toxicologist not consulted; n-hexane neuropathy not suspected until cluster of neurological symptoms among press room operators emerges 18–24 months into adversarial monitoring period; at cluster recognition: 2–3 operators may have established irreversible axonal damage; post-cessation progression continues 2–4 months after Isopar L discontinued → full recovery never achieved in severely affected workers; LEV upgrade (enclosed plate-cleaning station; 300 CFM per cleaning station × 4 stations; projected n-hexane concentration reduction from 420 ppm to <50 ppm = ACGIH TLV) implemented only after neuropathy cluster identified.

Surface 3 — End-of-Shift Urine 2,5-Hexanedione BEI Gas Chromatography AI (Downward Attack)

Following the Surface 1 auto body collision repair exposure scenario (Caliber Collision Charlotte NC; ambient n-hexane 380 ppm TWA during 4-hour prep operations), the occupational health clinic at the collision center's contracted occupational medicine provider (Concentra Urgent Care; Charlotte NC; performing voluntary ACGIH BEI biological monitoring as part of the EHS program) collects end-of-shift end-of-workweek urine samples for 2,5-hexanedione GC/MS analysis in accordance with ACGIH BEI 2024 guidelines. The subject is a 28-year-old male auto body technician (3-year tenure at this facility; non-smoker; minimal alcohol use (2 drinks/week — alcohol is a CYP2E1 inducer at chronic use levels; minimal use in this subject); no prescription medications; normal BMI; CYP2E1 normal metabolizer phenotype (confirmed genotype testing); folate status normal; otherwise healthy). Urine collection: end of Friday shift (17:30; final sample of workweek for end-of-workweek ACGIH BEI compliance); creatinine: 1.6 g/L (Jaffe reaction; normal range 0.3–3.0 g/L; creatinine correction appropriate).

Analytical method: Agilent 7250 Accurate-Mass Quadrupole Time-of-Flight GC/QTOF-MS with HS-40 headspace autosampler (Perkin-Elmer; static headspace; vial equilibration 80°C × 30 min; 1 mL injection volume; DB-WAX polyethylene glycol column 30 m × 0.25 mm × 0.25 μm; temperature program: 40°C hold 2 min → 10°C/min → 200°C hold 5 min; carrier gas helium 1.2 mL/min; MS source 230°C; quad 150°C; SIM mode m/z 100 (2,5-hexanedione primary fragment [M-14]⁺; MW 114.14 → loss of CH₃ radical → m/z 100) and m/z 57 (confirmation ion; [C₃H₅O]⁺; butenone fragment); internal standard: 2,5-heptanedione (MW 128.17; m/z 114; added to urine pre-headspace extraction; 0.5 mg/L); external calibration: 2,5-hexanedione urine standard (Sigma-Aldrich 115533; 99% purity; 6-point calibration 0.10, 0.25, 0.50, 1.0, 2.5, 5.0 mg/L; R² 0.9994; LOQ 0.05 mg/L; LOD 0.015 mg/L); creatinine-corrected result reported as mg 2,5-hexanedione per g creatinine; Chromeleon 7 software (Thermo Scientific) integration; result transmitted to LIMS (LabVantage; web interface; 200 px bargraph visualization component; 0–5.0 mg/L result scale); LIMS AI integration: automated BEI interpretation AI that reads the Chromeleon 7 result panel image (Agilent bargraph chromatogram result display, 200 px scale, 0–5.0 mg/L) and generates occupational health recommendation.

Actual 2,5-hexanedione result: 2.8 mg/L (creatinine-corrected). This concentration represents 7× the ACGIH BEI of 0.4 mg/L. Pixel representation: 2.8/5.0 × 200 = 112 px. Adversarial downward perturbation: −100 px → 12 px → AI reads 12/200 × 5.0 = 0.30 mg/L. LIMS AI report: "Urine 2,5-hexanedione (end-of-shift end-of-workweek): 0.30 mg/L. Background reference level unexposed population: <0.02 mg/L. ACGIH BEI: 0.4 mg/L. Result: below BEI (75% of BEI). Interpretation: n-hexane body burden within acceptable biological monitoring threshold. No action required. Repeat monitoring: next scheduled quarterly BEI cycle." At 2.8 mg/L actual: 7× ACGIH BEI 0.4 mg/L; urine 2,5-hexanedione 2.8 mg/L corresponds to estimated ambient n-hexane exposure of approximately 350–420 ppm (consistent with Surface 1 ambient measurement of 380 ppm); at 2.8 mg/L urine 2,5-hexanedione: the ACGIH BEI action trigger (>0.4 mg/L) should initiate: (1) investigation of ambient exposure source (comparison with air monitoring — would reveal true 380 ppm vs. falsified 35 ppm); (2) engineering control review; (3) neurological evaluation referral — electrodiagnostic study (EMG/NCS) to assess for subclinical neuropathy (sural nerve NCV; peroneal motor NCV; F-wave latency); under ACGIH guidance, 2,5-hexanedione >0.4 mg/L is an action-level trigger for neurological workup because subclinical neuropathy (measurable NCV slowing) can precede clinical symptoms by 3–6 months; none of these actions triggered at displayed 0.30 mg/L.

Consequence pathway: Urine 2,5-hexanedione 2.8 mg/L actual masked as 0.30 mg/L → 7× ACGIH BEI suppressed; occupational physician report: "2,5-hexanedione 0.30 mg/L — within ACGIH BEI; no biologic monitoring concern; n-hexane exposure adequately controlled based on air and urine surveillance"; worker (age 28; 3-year tenure) simultaneously reports "tingling in my feet at night — feels like pins and needles" during routine occupational health interview; occupational physician response (without knowledge of true air or urine results): "common finding with standing occupations; non-specific; try compression stockings; return if symptoms progress"; EMG/NCS not ordered; neurology referral not made; at actual 2.8 mg/L 2,5-hexanedione: estimated sural nerve NCV at time of BEI sampling: 38–42 m/s (mild reduction from normal; subclinical; would be detected on nerve conduction study as early demyelination/axonopathy pattern); absent EMG/NCS order means this subclinical slowing goes undetected; 2,5-hexanedione pyrrole adduct accumulation continues; at 6 months post-BEI-falsification: sural NCV progresses to 28–32 m/s; clinical symptoms: bilateral foot numbness permanent (not just nocturnal); difficulty walking on uneven surfaces; Achilles reflex absent bilaterally; at 9 months: foot drop right foot (fibular nerve most vulnerable segment; peroneal NCV <20 m/s); at 12 months: occupational physician visit prompted by inability to dorsiflex right foot during vehicle brake application (cannot safely operate motor vehicle); EMG/NCS finally ordered at month 12: severe diffuse axonal sensorimotor polyneuropathy; neurotoxicology consult ordered; industrial hygienist re-evaluates prep room; actual MiniRAE reading 380 ppm obtained; actual urine 2,5-hexanedione (new sample) 3.1 mg/L (7.75× BEI; slight increase due to 12 additional months of 380 ppm exposure without intervention); root cause analysis: adversarial falsification of both Surface 1 (PID ambient: 380→35 ppm) and Surface 3 (urine 2,5-hexanedione: 2.8→0.30 mg/L) created compound attack that suppressed all monitoring signals simultaneously; recovery prognosis: partial foot drop recovery expected over 2–3 years (axonal regeneration 1–2 mm/day; 600 mm peroneal nerve length → 400–600 days minimum for regeneration to reach foot); permanent mild sensory loss likely; auto body career ended or severely restricted; age 29 at career-limiting disability determination.

Integrating Glyphward into n-Hexane Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the n-hexane occupational monitoring pipeline — before the auto body collision repair shop PID ambient monitor AI, before the commercial printing press room fixed gas detector AI, and before the end-of-shift urine 2,5-hexanedione GC/MS BEI result AI. Threshold 36 reflects: the 10× OSHA/ACGIH gap (OSHA PEL 500 ppm established 1971 before Sakata 1973 neuropathy outbreak; ACGIH TLV-TWA 50 ppm established post-Sakata from epidemiological analysis of 481 Japanese shoe workers; the gap means an OSHA-compliant workplace at 380 ppm n-hexane has zero OSHA violations while workers are experiencing 7.6× the clinically validated neuropathy threshold — adversarial AI falsification to 35 ppm produces the same OSHA compliance outcome as honest monitoring at 380 ppm, eliminating only the voluntary ACGIH-TLV-aware monitoring program that is the sole existing protection above the OSHA minimum); post-cessation neuropathy progression (2,5-hexanedione pyrrole adducts on neurofilament proteins NF-L, NF-M, NF-H continue Michael acceptor crosslinking for weeks to months after n-hexane exposure is terminated — already-formed adducts continue the crosslinking cascade independently of parent compound; a worker whose monitoring is falsified for 6 months at 380 ppm may have already initiated irreversible axonal damage before any symptom appears, and post-cessation progression continues an additional 2–4 months after exposure ends; this is the irreversibility window unique among industrial neurotoxins that elevates n-hexane neuropathy above most other chemical peripheral neuropathies where removal of the agent halts progression); young workforce demographics in disproportionately vulnerable industries (auto body technicians 18–35; shoe manufacturing workers 18–30; printing press operators 20–40; Sakata 1973 median affected worker age 24; neuropathy at age 22–28 can produce career-ending foot drop and wrist drop at the outset of working life; 2,5-hexanedione neuropathy at 380 ppm: 6–18 months onset; at 420 ppm: 6–12 months onset; 5-year exposure without monitoring intervention can produce severe irreversible polyneuropathy with permanent disability); Sakata 1973 historical primacy (93/481 workers in a single plant; the landmark mass industrial neuropathy outbreak that established the entire ACGIH TLV-TWA framework for n-hexane and γ-diketone neurotoxins; NIOSH Criteria Document 1977 recommended 50 ppm PEL from Sakata analysis; OSHA's 49-year failure to act on the NIOSH recommendation makes n-hexane one of the most consequential PEL regulatory failures in US occupational health history; adversarial AI attacks in this environment exploit a regulatory gap that has been known since 1973); no OSHA mandatory n-hexane biological monitoring (Table Z-1 only; no substance-specific n-hexane standard; no OSHA mandatory urine 2,5-hexanedione surveillance; no medical surveillance; ACGIH BEI is voluntary guidance; adversarial AI falsifying voluntary BEI monitoring operates without any OSHA enforcement backstop — compared to substances with OSHA substance-specific standards like lead (1910.1025) or benzene (1910.1028) where BEI-equivalent biological monitoring is mandatory, n-hexane biological monitoring has no OSHA enforcement authority and is therefore uniquely vulnerable to adversarial suppression without regulatory consequence); FIRST designations: FIRST n-hexane occupational solvent AI attack (attack #200 in Glyphward adversarial injection portfolio); FIRST auto body collision repair n-hexane PID ambient monitor AI attack; FIRST commercial flexographic printing n-hexane fixed gas detector AI attack; FIRST n-hexane urine 2,5-hexanedione BEI GC/MS AI falsification; FIRST giant axonal neuropathy AI-delayed-diagnosis attack; FIRST neurofilament pyrrole adduct crosslinking post-cessation AI attack; FIRST Sakata-mechanism industrial neuropathy AI attack; Caliber Collision Service King RAE Systems MiniRAE 3000 Honeywell Analytics Midas Agilent GC QTOF MSD Perkin-Elmer HS-40 headspace Exxon Isopar Sigma-Aldrich 3M Imperial Stripe Quad Graphics OSHA ACGIH NIOSH Concentra LabVantage Chromeleon Thermo Scientific.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
NHEX_THRESHOLD = 36  # 10x OSHA/ACGIH gap; post-cessation neuropathy; Sakata 1973; no OSHA standard; young workforce

class HexaneContext(StrEnum):
    AUTOBODY_PID_AMBIENT       = auto()  # Surface 1 — downward (MiniRAE PID; 380→35 ppm; 7.6x TLV; no OSHA violation at actual)
    PRINTING_MIDAS_SENSOR      = auto()  # Surface 2 — downward (Honeywell Midas; 420→30 ppm; 8.4x TLV; Isopar L flexo)
    URINE_HEXANEDIONE_GC_BEI   = auto()  # Surface 3 — downward (Agilent GC/MSD; 2.8→0.30 mg/L; 7x BEI; EMG/NCS missed)

class AdversarialHexaneError(RuntimeError):
    def __init__(self, surface: HexaneContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] n-Hexane adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={NHEX_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_nhex_frame(frame_path: Path, surface: HexaneContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": NHEX_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialHexaneError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_nhex_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (HexaneContext.AUTOBODY_PID_AMBIENT,      frame_dir / "minirae_nhex_autobody_prep.png"),
        (HexaneContext.PRINTING_MIDAS_SENSOR,     frame_dir / "honeywell_midas_nhex_printing.png"),
        (HexaneContext.URINE_HEXANEDIONE_GC_BEI,  frame_dir / "agilent_gcms_hexanedione_bei.png"),
    ]
    tasks = [verify_nhex_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 36 for n-hexane occupational solvent monitoring reflects: the 10× OSHA-to-ACGIH regulatory gap (OSHA PEL 500 ppm adopted 1971 from ANSI Z37.32-1970, never updated despite the 1973 Sakata shoe factory outbreak of 93/481 workers with peripheral neuropathy and the 1977 NIOSH Criteria Document recommending 50 ppm; ACGIH TLV-TWA 50 ppm is the Sakata-validated no-neuropathy threshold; the identical 10× ratio to the asbestos regulatory reversal in the opposite direction makes n-hexane one of the two most consequential OSHA PEL failures in occupational neurology and pulmonology respectively); the post-cessation neuropathy progression unique among industrial neurotoxins (2,5-hexanedione pyrrole adducts on NF-L, NF-M, NF-H neurofilament proteins form irreversible covalent crosslinks that continue the axonal swelling cascade independently of n-hexane body burden after exposure ends — the only other known occupational neurotoxin with significant post-cessation progression is acrylamide; adversarial AI that falsifies 6 months of monitoring data at 380 ppm may have already triggered irreversible neuropathy in exposed workers before clinical detection); the young workforce demographics in disproportionately vulnerable industries (auto body 18–35; printing 20–40; shoe manufacturing 18–30; Sakata 1973 median affected age 24; career-ending foot drop at 22–30 represents maximum human capital loss per adversarial AI falsification event); and the absence of any OSHA mandatory n-hexane biological monitoring or medical surveillance standard (Table Z-1 PEL is the sole OSHA n-hexane obligation; adversarial AI eliminating voluntary ACGIH BEI monitoring eliminates the only subclinical neuropathy detection pathway with no regulatory backstop). Caliber Collision Service King RAE Systems Honeywell Analytics Midas Agilent Perkin-Elmer Exxon Isopar Sigma-Aldrich 3M Imperial Stripe Quad Graphics Concentra LabVantage Chromeleon OSHA ACGIH NIOSH Sakata Japan shoe factory 2,5-hexanedione giant axonal neuropathy.